Sharenet Sites 
Sharenet Sites
Dealings in securities by a director and the company secretary and by directors of a major subsidiary
LIFE HEALTHCARE GROUP HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 2003/002733/06)
ISIN: ZAE000145892
Share Code: LHC
(“Life Healthcare” or “the Company”)
DEALINGS IN SECURITIES BY A DIRECTOR AND THE COMPANY SECRETARY AND BY
DIRECTORS OF A MAJOR SUBSIDIARY
In compliance with the JSE Limited Listings Requirements, the following information is
disclosed:
Director : Petrus Phillippus van der Westhuizen
Company : Life Healthcare Group Holdings Limited
Nature of transaction : Off-market vesting of shares in terms of the Life
Healthcare 2014 Long Term Incentive Plan (LTIP)
and on-market disposal of the co-investment and
Company matched shares and the co-investment
and Company matched rights offer shares.
Number of shares vested and sold : 19 890 (Co-investment and Company matched LTIP
shares)*
6 806 (Co-investment and Company matched
rights offer shares)**
Vesting date : 31 January 2019
Date of transaction : 31 January 2019
Class of securities : Ordinary shares
Volume weighted average price per : R27.2383
share
Highest price : R27.78
Lowest price : R27.10
Total value of transaction : R727 153.66
Nature of interest : Direct Beneficial
Clearance obtained : Yes
Company Secretary : Fazila Patel
Company : Life Healthcare Group Holdings Limited
Nature of transaction : Off-market vesting of shares in terms of the Life
Healthcare 2014 Long Term Incentive Plan (LTIP)
and on-market disposal of the co-investment and
Company matched shares and the co-investment
and Company matched rights offer shares.
Number of shares vested and sold : 12 092 (Co-investment and Company matched LTIP
shares)*
4 137 (Co-investment and Company matched
rights offer shares)**
Vesting date : 31 January 2019
Date of transaction : 31 January 2019
Class of securities : Ordinary shares
Volume weighted average price per : R27.2383
share
Highest price : R27.78
Lowest price : R27.10
Total value of transaction : R442 050.37
Nature of interest : Direct Beneficial
Clearance obtained : Yes
Director : Pieter Francois Theron
Company : Life Healthcare Group (Proprietary) Limited a
major subsidiary of the Company
Nature of transaction : Off-market vesting shares in terms of the Life
Healthcare 2014 Long Term Incentive Plan (LTIP)
and on-market disposal of the co-investment and
ompany matched shares and the co-investment
and Company matched rights offer shares.
Number of shares vested and sold : 9 923 (Co-investment and Company matched LTIP
shares)*
3 395 (Co-investment and Company matched
rights offer shares)**
Vesting date : 31 January 2019
Date of transaction : 31 January 2019
Class of securities : Ordinary shares
Volume weighted average price per : R27.2383
share
Highest price : R27.78
Lowest price : R27.10
Total value of transaction : R362 759.68
Nature of interest : Direct Beneficial
Clearance obtained : Yes
Director : Kurt Aston Wylie
Company : Life Healthcare Group (Proprietary) Limited a
major subsidiary of the Company
Nature of transaction : Off-market vesting of shares in terms of the Life
Healthcare 2014 Long Term Incentive Plan (LTIP)
and on-market disposal of the co-investment and
Company matched shares and the co-investment
and Company matched rights offer shares.
Number of shares vested and sold 6 175 (Co-investment and Company matched LTIP
shares)*
2 113 (Co-investment and Company matched
rights offer shares)**
Vesting date : 31 January 2019
Date of transaction : 31 January 2019
Class of securities : Ordinary shares
Volume weighted average price per : R27.2383
share
Highest price : R27.78
Lowest price : R27.10
Total value of transaction : R225 751.03
Nature of interest : Direct Beneficial
Clearance obtained : Yes
Director : Craig Koekemoer
Company : Life Healthcare Group (Proprietary) Limited a
major subsidiary of the Company
Nature of transaction : Off-market vesting of shares in terms of the Life
Healthcare 2014 Long Term Incentive Plan (LTIP)
and on-market disposal of the co-investment and
Company matched shares.
Prior to his appointment as a director of a major
subsidiary of the Company, Mr Koekemoer elected
to purchase
3 750 Life Healthcare shares on-market in terms of
the LTIP in January 2017, at R35.0473 per share,
and was awarded 6 356 Company matched shares
in 2017, restricted for two years.
In April 2017, Mr Koekemoer purchased 3 056 Life
Healthcare shares off-market in terms of the rights
offer in respect of the LTIP co-investment shares
and the Company purchased 5 181 ordinary shares
off-market in terms of the rights offer in respect of
the LTIP Company matched shares. The rights
offer price was R24.50
Number of shares vested and sold : 10 106 (Co-investment and Company matched LTIP
shares)
3 458 (Co-investment and Company matched
rights offer shares)
Vesting date : 31 January 2019
Date of transaction : 31 January 2019
Class of securities : Ordinary shares
Volume weighted average price per : R27.2383
share
Highest price : R27.78
Lowest price : R27.10
Total value of transaction : R369 460.30
Nature of interest : Direct Beneficial
Clearance obtained : Yes
*Shareholders are referred to the SENS announcements published on 27 January 2017 where shareholders were advised that the chief financial
officer, the company secretary and the directors of the major subsidiary had purchased a number of Life Healthcare shares on-market in terms of
the LTIP.
**Shareholders are referred to the SENS announcement published on 4 April 2017 where shareholders were advised that the chief financial
officer, the company secretary and the directors of the major subsidiary had purchased a number of Life Healthcare rights offer shares off-market in
terms of the LTIP.
Illovo
4 February 2019
Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)
Date: 04/02/2019 04:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
